Biomarin Pharmaceutical (MIL:1BMRN) Inventory Turnover : 0.11 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Biomarin Pharmaceutical Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Biomarin Pharmaceutical's Cost of Goods Sold for the three months ended in Mar. 2024 was €115 Mil. Biomarin Pharmaceutical's Average Total Inventories for the quarter that ended in Mar. 2024 was €1,031 Mil. Biomarin Pharmaceutical's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.11.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Biomarin Pharmaceutical's Days Inventory for the three months ended in Mar. 2024 was 817.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biomarin Pharmaceutical's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.73.

Biomarin Pharmaceutical Inventory Turnover Historical Data

The historical data trend for Biomarin Pharmaceutical's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomarin Pharmaceutical Inventory Turnover Chart

Biomarin Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventory Turnover

Get a 7-Day Free Trial

0.60

0.73

0.66

0.60

0.51

Biomarin Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventory Turnover	Get a 7-Day Free Trial															0.15	0.13	0.13	0.13	0.11

Biomarin Pharmaceutical Inventory Turnover Calculation

Biomarin Pharmaceutical's Inventory Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Inventory Turnover (A: Dec. 2023 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2023 )	/ (	(Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )
=	472.121	/ (	(844.014	+	1015.287)	/	2 )
=	472.121	/	929.6505
=	0.51

Biomarin Pharmaceutical's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

	Inventory Turnover (Q: Mar. 2024 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2024 )	/ (	(Total Inventories (Q: Dec. 2023 )	+	Total Inventories (Q: Mar. 2024 ))	/	count )
=	115.165	/ (	(1015.287	+	1046.943)	/	2 )
=	115.165	/	1031.115
=	0.11

Biomarin Pharmaceutical (MIL:1BMRN) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biomarin Pharmaceutical's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2024 )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
	=	1031.115	/	115.165	*	365 / 4
	=	817.00

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biomarin Pharmaceutical's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	1031.115	/	596.926
	=	1.73

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Biomarin Pharmaceutical Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Biomarin Pharmaceutical's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomarin Pharmaceutical (MIL:1BMRN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomarin Pharmaceutical Inc (MIL:1BMRN) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

BMRN:USA BM8:Germany B1MR34:Brazil

Address

770 Lindaro Street, San Rafael, CA, USA, 94901

Website

http://www.bmrn.com

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). Voxzogo (vosoritide) was approved in achondroplasia in 2021. BioMarin's Roctavian (hemophilia A gene therapy) was approved in Europe in 2022 and in the U.S. in 2023.

Biomarin Pharmaceutical (MIL:1BMRN) Headlines

No Headlines